isradipine has been researched along with Postoperative Complications in 10 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
Postoperative Complications: Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Compare the efficacy of isradipine to that of nicardipine for the control of arterial hypertension following coronary artery bypass graft (CABG)." | 9.10 | [Comparison of nicardipine and isradipine in hypertension following coronary artery bypass graft]. ( Achkouty, R; Antakly, MC; Haddad, F; Hayek, G; Khater-Rassi, D; Madi-Jebara, S; Yazigi, A, 2002) |
| "Intravenous isradipine was effective and well tolerated in patients with hypertension after CABG and offers an additional therapeutic option to treat patients after cardiac surgery." | 9.07 | Treatment of postoperative hypertension after coronary artery bypass surgery. Double-blind comparison of intravenous isradipine and sodium nitroprusside. ( Brister, N; Cohen, M; Hines, R; Leslie, J; Levy, JH; Martin, H; Marty, A; Savino, J; Yared, JP, 1994) |
| "In a randomized trial, a calcium antagonist, isradipine (ISR) and sodium nitroprusside (SNP) were compared in the management of hypertension in the early period following coronary artery bypass grafting (CABG)." | 9.07 | Isradipine for the treatment of hypertension following coronary artery bypass graft surgery: a randomized trial versus sodium nitroprusside. ( David, D; Loria, Y; Ruegg, PC, 1992) |
| "To evaluate the efficacy and duration of action of iv isradipine in the control of postoperative hypertension immediately after myocardial revascularization." | 7.68 | Isradipine for treatment of acute hypertension after myocardial revascularization. ( Alpern, J; Barnette, RE; Brister, NW; McClurken, JB; Schartel, SA, 1991) |
| " Both agents were able to achieve reductions in MAP to 80-90 mmHg quickly and safely, although the effects of isradipine at the dosage used were apparent sooner and gave smoother control than with sodium nitroprusside." | 6.67 | Comparative study of isradipine and sodium nitroprusside in the control of hypertension in patients following coronary artery-bypass surgery. ( Chan, E; De Lange, S; Lawrence, CJ; Lestrade, A, 1993) |
| "Compare the efficacy of isradipine to that of nicardipine for the control of arterial hypertension following coronary artery bypass graft (CABG)." | 5.10 | [Comparison of nicardipine and isradipine in hypertension following coronary artery bypass graft]. ( Achkouty, R; Antakly, MC; Haddad, F; Hayek, G; Khater-Rassi, D; Madi-Jebara, S; Yazigi, A, 2002) |
| "Intravenous isradipine was effective and well tolerated in patients with hypertension after CABG and offers an additional therapeutic option to treat patients after cardiac surgery." | 5.07 | Treatment of postoperative hypertension after coronary artery bypass surgery. Double-blind comparison of intravenous isradipine and sodium nitroprusside. ( Brister, N; Cohen, M; Hines, R; Leslie, J; Levy, JH; Martin, H; Marty, A; Savino, J; Yared, JP, 1994) |
| "In a randomized trial, a calcium antagonist, isradipine (ISR) and sodium nitroprusside (SNP) were compared in the management of hypertension in the early period following coronary artery bypass grafting (CABG)." | 5.07 | Isradipine for the treatment of hypertension following coronary artery bypass graft surgery: a randomized trial versus sodium nitroprusside. ( David, D; Loria, Y; Ruegg, PC, 1992) |
| "To evaluate the efficacy and duration of action of iv isradipine in the control of postoperative hypertension immediately after myocardial revascularization." | 3.68 | Isradipine for treatment of acute hypertension after myocardial revascularization. ( Alpern, J; Barnette, RE; Brister, NW; McClurken, JB; Schartel, SA, 1991) |
| " Both agents were able to achieve reductions in MAP to 80-90 mmHg quickly and safely, although the effects of isradipine at the dosage used were apparent sooner and gave smoother control than with sodium nitroprusside." | 2.67 | Comparative study of isradipine and sodium nitroprusside in the control of hypertension in patients following coronary artery-bypass surgery. ( Chan, E; De Lange, S; Lawrence, CJ; Lestrade, A, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (80.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prisant, LM | 1 |
| Spaulding, VC | 1 |
| Brogden, RN | 1 |
| Sorkin, EM | 1 |
| Leslie, J | 1 |
| Brister, N | 1 |
| Levy, JH | 1 |
| Yared, JP | 1 |
| Marty, A | 1 |
| Martin, H | 1 |
| Hines, R | 1 |
| Savino, J | 1 |
| Cohen, M | 1 |
| Marty, J | 1 |
| Lawrence, CJ | 1 |
| Lestrade, A | 1 |
| Chan, E | 1 |
| De Lange, S | 1 |
| van den Dorpel, MA | 1 |
| Zietse, R | 1 |
| Ijzermans, JN | 1 |
| Weimar, W | 1 |
| Madi-Jebara, S | 1 |
| Khater-Rassi, D | 1 |
| Yazigi, A | 1 |
| Haddad, F | 1 |
| Hayek, G | 1 |
| Achkouty, R | 1 |
| Antakly, MC | 1 |
| Ruegg, PC | 1 |
| David, D | 1 |
| Loria, Y | 1 |
| Brister, NW | 1 |
| Barnette, RE | 1 |
| Schartel, SA | 1 |
| McClurken, JB | 1 |
| Alpern, J | 1 |
2 reviews available for isradipine and Postoperative Complications
| Article | Year |
|---|---|
Isradipine. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of mild to moderate hypertension.
Topics: Cardiac Surgical Procedures; Clinical Trials as Topic; Drug Interactions; Drug Therapy, Combination; | 1995 |
Role of isradipine and other antihypertensive agents in the treatment of peri- and postoperative hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Calcium Channel Blockers; Humans; Hyperte | 1993 |
5 trials available for isradipine and Postoperative Complications
| Article | Year |
|---|---|
Treatment of postoperative hypertension after coronary artery bypass surgery. Double-blind comparison of intravenous isradipine and sodium nitroprusside.
Topics: Coronary Artery Bypass; Double-Blind Method; Female; Hemodynamics; Humans; Hypertension; Infusions, | 1994 |
Comparative study of isradipine and sodium nitroprusside in the control of hypertension in patients following coronary artery-bypass surgery.
Topics: Adolescent; Adult; Aged; Coronary Artery Bypass; Female; Hemodynamics; Humans; Hypertension; Infusio | 1993 |
Prophylactic isradipine treatment after kidney transplantation: a prospective double-blind placebo-controlled randomized trial.
Topics: Adult; Antilymphocyte Serum; Blood Pressure; Calcium Channel Blockers; Cyclosporine; Double-Blind Me | 1994 |
[Comparison of nicardipine and isradipine in hypertension following coronary artery bypass graft].
Topics: Aged; Antihypertensive Agents; Calcium Channel Blockers; Coronary Artery Bypass; Female; Hemodynamic | 2002 |
Isradipine for the treatment of hypertension following coronary artery bypass graft surgery: a randomized trial versus sodium nitroprusside.
Topics: Adult; Aged; Calcium Channel Blockers; Coronary Artery Bypass; Dihydropyridines; Female; Humans; Hyp | 1992 |
3 other studies available for isradipine and Postoperative Complications
| Article | Year |
|---|---|
Antihypertensive pharmacobezoar.
Topics: Antihypertensive Agents; Bezoars; Calcium Channel Blockers; Drug Delivery Systems; Gastrointestinal | 2006 |
Update on perioperative hypertension: the place of intravenous isradipine. Proceedings of a workshop. Sonoma, California, October 26, 1991.
Topics: Animals; Humans; Hypertension; Intraoperative Complications; Isradipine; Postoperative Complications | 1993 |
Isradipine for treatment of acute hypertension after myocardial revascularization.
Topics: Aged; Antihypertensive Agents; Calcium Channel Blockers; Coronary Artery Bypass; Female; Hemodynamic | 1991 |